Mepivastesin (Mepivacaine Hydrochloride)

Mepivacaine works by reversibly blocking voltage‑gated sodium channels on nerve membranes. This inhibition prevents sodium influx, stopping the generation and propagation of action potentials, which results in a temporary loss of sensation in the area where the drug is administered.

The appropriate dose of Mepivastesin is determined by the prescribing clinician based on the procedure, site of injection, patient weight, and overall health. Dosage guidelines are provided in the product label and must be individualized for each patient.

Safety data for mepivacaine in pregnancy and lactation are limited. It should only be used when the potential benefit justifies any potential risk to the fetus or infant, and the decision should be made by the treating physician.

To order Mepivastesin, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details, and any necessary import documentation.

Mepivastesin (mepivacaine) is an amide‑type local anesthetic with a rapid onset and intermediate duration, similar to lidocaine but with slightly longer analgesia and less vasodilatory effect. It is often chosen when a moderate duration of action is desired without the need for a vasoconstrictor.

Mepivastesin should be stored at room temperature, below 25 °C, in its original sealed container. Protect the solution from direct light and moisture, and keep it out of reach of children.

Mepivastesin is administered by infiltration or perineural injection using a sterile syringe and needle. The clinician injects the solution directly into the target tissue or around the nerve bundle, following aseptic technique and aspiration to avoid intravascular delivery.

Serious risks include allergic reactions, systemic toxicity leading to seizures or cardiac arrhythmias, and rare cases of methemoglobinemia. Prompt recognition of symptoms such as ringing in the ears, metallic taste, or cardiovascular changes is essential for immediate management.

Mepivastesin should not be used in patients with a known hypersensitivity to mepivacaine, other amide‑type local anesthetics, or any component of the formulation. Caution is also advised in individuals with severe cardiac conduction disorders or uncontrolled epilepsy.